Supernus Pharma's ADHD drug meets main goal in late-stage trial
December 20, 2018 at 07:12 AM EST
Supernus Pharmaceuticals Inc said on Thursday its drug for attention deficit hyperactivity disorder met the main goal in a late-stage study testing in adolescents.
